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Abstract
Background: The secondary use of health data for research raises complex questions of privacy and governance. Such questions
are ill-suited to opinion polling where citizens must choose quickly between multiple-choice answers based on little information.
Objective: The aim of this project was to extend knowledge about what control informed citizens would seek over the use of
health records for research after participating in a deliberative process using citizens’ juries.
Methods: Two 3-day citizens’ juries, of 17 citizens each, were convened to reflect UK national demographics from 355 eligible
applicants. Each jury addressed the mission “To what extent should patients control access to patient records for secondary use?”
Jurors heard from and questioned 5 expert witnesses (chosen either to inform the jury, or to argue for and against the secondary
use of data), interspersed with structured opportunities to deliberate among themselves, including discussion and role-play. Jurors
voted on a series of questions associated with the jury mission, giving their rationale. Individual views were polled using
questionnaires at the beginning and at end of the process.
Results: At the end of the process, 33 out of 34 jurors voted in support of the secondary use of data for research, with 24 wanting
individuals to be able to opt out, 6 favoring opt in, and 3 voting that all records should be available without any consent process.
When considering who should get access to data, both juries had very similar rationales. Both thought that public benefit was a
key justification for access. Jury 1 was more strongly supportive of sharing patient records for public benefit, whereas jury 2 was
more cautious and sought to give patients more control. Many jurors changed their opinion about who should get access to health
records: 17 people became more willing to support wider information sharing of health data for public benefit, whereas 2 moved
toward more patient control over patient records.
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Conclusions: The findings highlight that, when informed of both risks and opportunities associated with data sharing, citizens
believe an individual’s right to privacy should not prevent research that can benefit the general public. The juries also concluded
that patients should be notified of any such scheme and have the right to opt out if they so choose. Many jurors changed their
minds about this complex policy question when they became more informed. Many, but not all, jurors became less skeptical
about health data sharing, as they became better informed of its benefits and risks.
(J Med Internet Res 2018;20(3):e112)  doi: 10.2196/jmir.7763
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Introduction
Public Opinion on Data Use
The last decade has seen a surge in the reuse of data that were
created for the health care of individual patients for additional
purposes such as for research (so-called secondary use of data).
Research studies that previously would have been impossible
because of the effort required to collect data have now become
possible by reusing data originally collected for the purposes
of providing direct health care. Examples include investigations
into the prescribing of anxiolytics and hypnotics in over 300,000
children and young people in Wales [1], the mental health of
57,000 veterans compared with173,000 nonveterans in Scotland
[2], and the impact of a smoke-free legislation on stroke [3].
In many countries, there is no lawful impediment to the use of
deidentified (or anonymized) data for research without the
consent of the data subject, as long as the risks of reidentification
are very low or remote. This may include the linkage of data
from multiple sources before deidentification. However, public
support for such research use of data without consent, the
so-called social license, is separate from any legal framework
[4]. Even where no legislation exists to prevent the use of
deidentified data, the lack of a social license may ultimately
result in the failure of data-use initiatives, as has been the case
with national data records systems in England [4] and Australia
[5].
Epidemiologists are dependent upon using data without consent
for such research for numerous reasons. Obtaining consent from
many thousands of people is an onerous task, and there is a
strong likelihood of many people being disinterested and not
giving consent simply because they do not remember being
asked [6]. Large amounts of missing data, which are often from
particular subgroups rather than randomly distributed through
the population, can mean that findings from epidemiological
studies can be misleading [7].
Despite such opinions in the aggregate, individual public
attitudes toward the secondary use of data vary [8,9]. In
particular, public support may be different, depending on who
is using the data or the use to which the data may be put. Such
reuse of data without consent is an area of concern to some
members of the public [10]. These people express the wish to
be asked to consent to every use of the data, whereas others
want to give a general consent for data use. Still others are
content with the data being used without them being aware,
consulted, or asked at all, provided that the research has been
reviewed and approved by an ethics committee [9].
Deliberative Approaches
It could be argued that, for such a complex area, surveys may
not be the best method to find out about the decisions that the
public would make. Members of the public are often unaware
of the ways that data are used and the governance procedures
that are put in place to protect health care data [8,10,11]. Thus,
it could be surmised that some survey respondents do so from
a position of ignorance of the topic. Qualitative methods such
as focus groups or deliberative processes provide a more
nuanced view of public opinion. Some of these methods,
particularly those which employ deliberative approaches, enable
questions to be answered about what citizens would think
regarding the use of data if they were informed. Few studies
have done this [11,12]. Recently, the Wellcome Trust compared
findings from a survey about the commercial use of data
conducted with 2017 members of the public, with findings from
16 focus groups with 246 people [11]. The focus groups
indicated how people change their minds once they were slightly
more informed about the use of data through discussion with
their peers in the group, whereas surveys are generally
conducted at a single point in time.
This suggests that there is much to be learned from using
deliberative methods that allow participants to learn about and
reflect on information about such a complex area. Citizens’
juries are comprehensive engagement processes that allow
decision makers and the public to hear thoughtful input from
an informed microcosm of the public [13]. They are based on
the premise that, given enough time, opportunity, support, and
resources, members of the public are quite capable of arriving
at decisions about complex matters [13,14]. The citizens’ jury
process is designed to allow decision makers to hear citizens’
voices. It provides an opportunity for citizens to learn about an
issue and deliberate together to find a common ground solution.
Decision makers can thus learn more about what an informed
public wants and why they want it [13].
There are examples of organizations using citizens’ juries to
help make policy decisions, even though members of juries are
not elected and cannot be made accountable for decisions. For
example, Melbourne City Council has appointed a citizens’ jury
to determine how to allocate its 10-year Aus $5 billion budget,
and the council is implementing virtually all of the jury’s
recommendations [15].
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Study Aim
The aim of this study was to investigate what people think about
secondary use of data, including data linkage, once they become
more informed about the area. The outcome of the citizens’
juries was to inform the ongoing research, information
governance, and public engagement strategies of the project’s
sponsors: the UK's national Farr Institute of Health Informatics
Research [16] and the Greater Manchester Primary Care Patient
Safety Translational Research Centre [17].
Methods
Jury Process
The citizens’ juries were run over 3 days as jury pairs [18], that
is, two juries were conducted in the same geographical area,
addressed the same jury mission (Textbox 1), listened to the
same witnesses, but were comprised of different people. To
ensure that the juries were conducted appropriately, the manual
written by the Jefferson Center, the developers of the method,
was followed [13], and the juries were run by an experienced
facilitator from that center (KB). Approval for video recording
of the jury discussions was obtained from The University of
Manchester’s research ethics committee.
Jury Recruitment
The citizens’ jury process uses members who are selected to be
representative of the population in key criteria [13]. Recruitment
questionnaires collected data to enable selection against a priori
criteria based on demographics and views on privacy (Table 1).
The demographics provided a broadly representative sample of
resident adults in England based on the 2011 census with respect
to gender, age range, ethnicity, and educational attainment [19].
Potential participants were asked to complete an Ipsos MORI
survey question [20] that involved balancing privacy against
information sharing for public benefit (Textbox 2). This was
the most up-to-date survey of public opinion in this area at the
time of recruitment. The demographic and privacy criteria
insured that each jury was a “microcosm of the public” [13].
Textbox 1. The jury mission.
Suppose a National Health Service (NHS) body wants to create new records from the patient records stored by your general practice and by hospitals
that have treated you. They want to use them for purposes other than your direct patient care, such as research about better treatments and for checking
that patients are receiving safe and effective health care. These records would be held securely and would not contain your name, address, and other
identifiers. Despite this, there is a small risk that the records might still identify you because they would contain lots of detailed information about the
care you receive from your general practitioner and from different hospitals. The NHS body would also review requests from other public and private
organizations, granting access only where they believed it was lawful and in a good cause.
1. i. Should the NHS body be allowed to create these records about you and other patients? (choose only one of the following)
a. Yes, but they should publish information about what they plan to do
b. Yes, but they should publish information about what they plan to do and patients should be able to opt out
c. Yes, but they should publish information about what they plan to do and only create records for patients who opt in
d. No
e. Other (explain in less than 30 words)
ii. Give reasons for your answer (in less than 300 words)
2. i. Given your answer to question 1, who should be allowed to access and extract data from the records created? (Choose as many of the
following examples that apply)
a. NHS clinicians and administrators who decide which health services should (and should not) be funded
b. NHS clinicians and administrators doing approved research into whether doctors are prescribing medicines appropriately
c. University staff doing approved research into whether doctors are prescribing medicines appropriately
d. Staff employed by local authorities planning the future need for residential care homes
e. Staff employed by a private company being paid by a hospital NHS trust to compare the number of people dying after surgery with
other hospitals
f. Staff employed by an insurance company aiming to set health insurance premiums accurately
g. Staff employed by a pharmaceutical company investigating whether they should begin research into a new drug for a genetic disease
for which there is currently no treatment
ii. Give reasons for your answer (in less than 400 words)
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Table 1. A priori criteria for jury selection and demographics of actual jurors.
Achieved in jury 1 and 2bJury target rangeUK census (%)aCriteria
Gender
8 and 9 jurors8-10 jurors51Women
9 and 8 jurors8-10 jurors49Men
Age range (years)
5 and 3 jurors2-5 jurors2118-29
4 and 6 jurors3-6 jurors2630-44
5 and 5 jurors3-6 jurors2545-59
3 and 3 jurors4-7 jurors2860+
Ethnicity
14 and 14 jurors14-17 jurors85White
3 and 3 jurors2-4 jurors15Groups other than white
Educational attainment
6 and 7 jurors5-8 jurors36Level 1 or no qualifications
6 and 5 jurors5-8 jurors37Level 2 or level 3 qualifications (apprenticeship and other qualifications)
5 and 5 jurors4-6 jurors27Level 4 qualifications (degree level) and above
Privacy viewsc
9 and 10 jurors7-11 jurors52Agree more with a) than b)
5 and 6 jurors5-7 jurors34Agree more with b) than with a)
3 and 1 jurors1-4 jurors14Agree equally with both or don’t agree with either or don’t know
a[19].
b1 person left each jury at the end of the first day and are not reported here.
cTarget sample percentages based on “Perceptions of Data Sharing” survey [20]—see Textbox 2 for full text.
Textbox 2. Ipsos MORI survey question used to assess views and privacy for jury selection and after the jury was completed.
As you may know, different government departments and services collect data about individuals, for example, your tax records and health records.
People have different views on how much of this information should be shared within government. Data sharing can bring benefits such as finding
more effective medical treatments, using information about local communities to plan local schools or roads, etc. But some people worry that data
sharing will be a risk to their privacy and security, by linking different types of data together and potentially allowing them to be identified. Overall,
which of the following statements is closest to your view?
a. We should share all the data we can because it benefits the services and me—as long as I can opt out if I choose
b. We should not share data as the risks to people’s privacy and security outweigh the benefits
1. Agree much more with a) than with b)
2. Agree a little more with a) than with b)
3. Agree equally or don’t agree or don’t know
4. Agree a little more with b) than with a)
5. Agree much more with b) than with a)
Jury members were recruited using a variety of methods to
ensure that the criteria were met. Adverts were placed on
websites for employment opportunities and research volunteers,
emails were sent to a range of community groups, and in-person
presentations were made to groups of retired people. Most of
the members were recruited from the employment website.
From a jury pool of 355 eligible applicants, 18 jurors and 4
reserves were selected for each jury, as recommended by the
Jefferson Center [13]. Candidates meeting the criteria in Table
1 were shortlisted and interviewed by telephone to check
eligibility, namely, older than 18 years; fluency in English; the
capacity to contribute to jury discussions; not a health care
professional; at least a year as a resident of Greater Manchester;
and no special knowledge, interest, or conflict of interest in the
jury mission. Jurors were thus chosen to ensure that they had
“no special axe to grind” [21].
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Reserves attended the jury meeting and stayed until lunchtime
on day 1. In each jury, one was needed to replace a juror who
did not attend or who had left during the first morning. Both
jurors and reserves were paid for their time. One person
withdrew from each jury at the end of day 1 for personal reasons.
As the reserves had not attended for the afternoon of day 1, and
therefore, had not heard the information presented by the
witnesses, these jurors were not replaced, leaving 17 people to
complete each jury.
Jury Process
The jury mission was planned, designed, and refined over a
period of 9 months by a project board comprising five of the
authors. The jury mission asked jurors to suppose that a National
Health Service (NHS) body wanted to create new records by
linking data from the patient records stored by their general
practice and by hospitals that have treated them. The new
records were for purposes other than direct patient care,
including research and service improvement. The jurors were
then asked whether this should be allowed and, if so, who should
be allowed access to the data. The mission was developed
iteratively by the project board to reflect the question on the
extent to which patients should control access to patient records
(Textbox 1). Both 3-day juries followed the same program
(Textbox 3). The activities were designed primarily by the
Jefferson Center in line with their citizens’ jury method [13]
and were managed by two facilitators who were independent
of the project board and jury sponsors (KB and AH).
Five expert witnesses were chosen to provide relevant
information to and answer any questions from the members of
the jury (Table 2). Two witnesses were selected to provide
impartial information on day 1, including about the use of
deidentified data using the Information Commissioner’s Office’s
(ICO’s) anonymization code of practice [22]. The code
emphasizes that understanding anonymization means
understanding what personal data is, that it can be impossible
to assess reidentification risk with absolute certainty, and that
different forms of access to anonymized data can pose different
reidentification risks (eg, publication is more risky than limited
access). Three advocates, known as partial witnesses, were
chosen to provide arguments for and against the greater use of
patient records on day 2. The purpose of the expert witness
presentations was “to inform and educate the jurors, a
microcosm of the public, to enable them to reach wise and
thoughtful conclusions” [13], rather than to produce. Impartial
expert witnesses were asked to confine their presentations and
answers to questions to matters of fact rather than values. Partial
expert witnesses were asked to make the case for a particular
viewpoint or viewpoints based on both facts and values, and an
ethicist was asked to provide arguments pulling in both
directions (Table 2; see Multimedia Appendix 1 for
presentations). The difference between the two types of
witnesses was explained to the jurors. After each presentation,
there was an opportunity for questions.
Textbox 3. The program of activities for both citizens’ juries.
Day 1:
• Participants complete the start-of-Jury questionnaire and consent form
• Introduction to the event
• Group work simulation exercise (about allocation of ambulance services)
• Presentation and questions with expert witness on patient records (Ralph Sullivan), and group work to identify key learning points
• Presentation and questions with expert witness on the law (Dawn Monaghan), and group work to identify key learning points
Day 2:
• Presentation and questions with expert witness arguing for greater use of patient records in the public interest (John Ainsworth), and group work
to identify key learning points
• Presentation and questions with expert witness arguing for protection and patient control of patient records (Sam Smith), and group work to
identify key learning points
• Presentation and questions with expert witness identifying ethical considerations (Søren Holm), and group work to identify key learning points
• Group work to identify, discuss, and rank reasons for and against the different components of question 1 of the jury mission
• Juror voting on question 1
Day 3:
• Group work with prepared information to develop the case for and against different parties gaining access to records, as set out in question 2 of
the jury mission
• Group work to identify, discus, and rank reasons for and against the different parties identified in question 2 of the jury mission
• Juror voting on question 2
• Participants complete the end-of-jury questionnaire
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Table 2. Perspectives taken and information provided by impartial and partial witnesses who presented to both juries.
Information providedPerspective takenWitnesses
Impartial witnesses
General Medical Council requirements for record
keeping, content of multiple patient records, and how
they are used in practice both for direct care and sec-
ondary uses
To explain what is in a patient record, and
how patient records are used in the NHS.
Dr Ralph Sullivan, general practitioner and
medical informatician
Outline of relevant privacy law, (common law duty of
confidence and Data Protection Act 1998), how data are
protected, and limitations to access to data
To tell jurors a little about the law that
protects access to patient records.
Dawn Monaghan, group manager for public
services at the Information Commissioner’s
Office
Partial witnesses
How data are used to create medical evidence as to the
effectiveness and safety of treatment in the public inter-
est
To argue that it’s important that patient
records are used for research and other
purposes that bring benefits to the public.
Dr John Ainsworth, senior research fellow
at the University of Manchester
Risks of reidentification, differences between opt out
and opt in, uses of data for decommissioning services,
and misuse by commercial companies. Argued the case
for greater control of patient records
Oo make the case for stronger control over
access to patient records and better infor-
mation and choices for patients about the
use of patient records.
Sam Smith, medConfidential coordinator
Potential benefits of sharing data, problems with sharing
data, and difficulties with specific informed consent
models. How these conflicting interests can be recon-
ciled. Identified ethical considerations both for patients
sharing and for patients controlling patient records for
uses other than direct patient care
Ethical arguments for patients controlling
access to patient records, and ethical argu-
ments for wider use of patient records for
the benefit of the public.
Professor Søren Holm, professor of
bioethics at the University of Manchester
Jury deliberations occurred in small groups after each
presentation and before the preparation of each section of the
final report. The small groups recorded and reported the results
of their deliberations back to the entire jury. During this time,
there were opportunities to seek clarification on points of fact
from the experts. In addition, if points had been misunderstood
by individual jury members, other jurors corrected them. Over
half of the total jury time was devoted to jury deliberations in
small groups or together as a large group.
To monitor and minimize bias, an independent oversight panel
was appointed. The panel members were chosen from national
organizations for their subject knowledge and lack of conflict
of interest: the chair of the Confidentiality Advisory Group [23],
the assistant director of the Nuffield Council on Bioethics [24],
and a senior policy officer from the ICO [25] with responsibility
for health data. The panel reviewed the citizens’ jury design,
the choice of expert witnesses, and much of the detailed jury
documentation, including the jury questionnaires and the slides
from the presentations by the impartial expert witnesses,
resulting in some changes to these materials.
Additional design controls used to monitor and minimize bias
included that the project board was only able to influence the
jury mission and was independent from the jury process and
outcomes. A day-long pilot workshop was conducted with seven
members of the public to test aspects of the jury design,
including presentations by two of the expert witnesses, some
of the planned jury activities, and the pre-and postquestionnaires.
This highlighted a number of issues, leading to design changes.
During the two juries, jury members were asked to complete a
questionnaire at the end of each day as to whether the jury
facilitators or anyone else had tried to influence them toward
particular conclusions. Paired juries were conducted to reduce
bias and validate outcome [18]. Finally, the detailed jury design
and results documentation were published online [26].
Jury Questionnaires and Reports
Jurors were asked to complete a questionnaire at the start of the
jury to identify their prior views and again after all the jury
deliberations were complete (Tables 3 and 4). Data were entered
into Excel (Microsoft) and collated using simple counts [13].
During the second half of the jury proceedings, the lead
facilitator constructed the juries’ report with each jury. The two
juries voted on individual aspects of both of the jury mission
questions (Textbox 1 and Table 3). Jurors also suggested reasons
for and against the jury mission options, and the most important
reasons given were chosen by juror voting. Each juror had three
votes that could be allocated to two or three of the reasons (no
reason could get all three votes). This voting method is now the
standard approach of the Jefferson Center, although not
described in the manual published in 2004 [13]. It allows jurors
to choose more than a single option, which is often desired when
faced with a large number of possible selections. These votes
and ranked reasons formed the basis of the jury reports. On the
afternoons of day 2 and day 3, the facilitator led the jurors
through the jury report displayed on a screen, editing in real
time in discussion with the jurors to gain their acceptance that
it fairly represented their views.
All jurors and reserves consented in writing for the main group
deliberations to be video recorded; small group deliberations
were not recorded. Eleven jurors from jury 1 also consented to
be interviewed briefly on video about their views on the jury
mission, to be used in a video about the jury findings [26]. Each
interview lasted approximately 3 min. Sections of the videos
pertaining to decision making, and the jury report were watched
repeatedly by the lead author (MPT). These discussions were
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compared with the final versions of the two jury reports that
had been prepared contemporaneously with the discussions.
Relevant portions of the videoed discussions were transcribed,
and verbatim quotes were selected for inclusion to highlight the
discussion content. Additional explanations are provided in the
quotes inside square brackets, where needed for clarity.
Results
Jury Process
The majority of jurors reported in their postjury questionnaires
that there was no evidence of bias in the conduct of the juries.
However, bias was reported by a few jurors, particularly
regarding what they perceived as the impartiality of information
from expert witnesses. Differences in quality of presentations
by the witnesses were interpreted by one juror as a deliberate
attempt to manipulate proceedings. In addition, one jury member
explained in their questionnaire:
The roles of the expert witnesses made them naturally
inclined to imply certain things, although nothing was
explicitly said to persuade us.
The majority of jurors reported participation in the jury process
to be very interesting (12 in jury 1 and 17 in jury 2) or mostly
interesting (4 members of jury 1). Throughout, the jury members
were fully engaged in the process of deliberation, as was evident
from the videos of the proceedings, and the quality of the report
that the jurors and facilitators produced.
Jury Questionnaires
Jurors completed the pre- and postjury questionnaires
individually (Tables 3 and 4). In jury 1, although 8 jurors did
not change their views, 9 jurors did, with 5 of them making
shifts in a way that favored public benefits over privacy. In jury
2, although 7 jurors did not change their views at all, 10 did,
although the shifts were not as marked as for jury 1. Although
6 jurors moved toward favoring public benefit, 2 moved more
toward favoring increased privacy. Figure 1 highlights the
changes in opinions of jurors.
At the end of the juries, 33 out of 34 jurors voted independently
in support of the secondary use of data, with 24 wanting
individuals to be able to opt out and 6 favoring opt-in
arrangements (Table 3). The remaining 3 wanted data users
only to publish their intentions, with no opportunity for either
opting in or out. The other suggestions that were given by the
jurors were additional requirements as to what data users should
be required to do. These included giving opt-out options to
children at 16 years and requiring an additional strong regulatory
body. One juror wrote on their questionnaire, “I feel if it was
an opt-out, people or organisations would just brush over it.
Whereas if they want the numbers, it will have to be thought
about and [the] public educated.” The reasons for opinion
changes were not explicitly ascertained from the jurors, but
some volunteered information. One juror expressed new
concerns and suspicions as to the rationale for conducting data
linkage and the role of the citizens’ jury in giving legitimacy
to that process.
Many jurors changed their opinion about who should get access
to these records, with more people supporting information
sharing to a wider group of people by the end of day 3 (Table
4). The aggregate numbers in the Table belie the fact that
individual jurors changed their minds in opposite directions.
Four jurors in jury 1 changed their minds about NHS researchers
accessing data, with 2 agreeing prejury but not postjury, and 2
agreed to allow access postjury but not prejury. Similarly in
jury 2, 6 jurors changed their view regarding both university
researchers and local authorities, with 3 moving from denying
to allowing access and the other 3 moving in the opposite
direction.
Table 3. Results from pre- and postjury questionnaires for jury mission question 1 completed individually by jurors, including changes in opinions.
“Change” indicates previous answer to new answer. NHS: National Health Service.
Jury 2 (n)Jury 1 (n)Question and answer options
ChangePostjuryChangePrejuryChangePostjuryChangePrejury
Should the NHS body be allowed to create these records about you and other patients?
b→a (2)20b→a (2)2a→b (2)2a. Yes, but they should publish infor-
mation about what they plan to do
b→b (7);
c→b (3)
10b→a (2);
b→b (7);
b→c (2);
b→e (1)
12a→b (2);
b→b (6);
c→b (5)
13b→a (2);
b→b (6)
8b. Yes, but they should publish infor-
mation about what they plan to do
and patients should be able to opt
out
b→c (2);
e→c (1)
3c→b (3);
c→e (1)
4c→c (1)1c→b (5);
c→c (1)
6c. Yes, but they should publish infor-
mation about what they plan to do
and only create records for patients
who opt in
0000d. No
b→e (1);
c→e (1)
2e→c (1)1e→e (1)1e→e (1)1e. Other
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Table 4. Results from pre- and post-jury questionnaires for jury mission question 2 completed individually by jurors, including changes in opinions.
“Change” indicates previous answer to new answer. Y=organization should be granted access; N=organization should not be granted access. NHS:
National Health Service.
Jury 2 (n)Jury 1 (n)Question and answer options
ChangePostjuryChangePrejuryChangePostjuryChangePrejury
Which organizations should be granted access to these records? (Choose all that apply)
NHS clinicians and administrators who decide which health services should (and should not) be funded
Y→Y (7);
N→Y (10)
17Y→Y (7)7Y→Y (10);
N→Y (5)
15Y→Y (10)10Yes
0N→Y (10)10N→N (2)2N→Y (5);
N→N (2)
7No
NHS clinicians and administrators doing approved research into whether doctors are prescribing medicines appropriately
Y→Y (14);
N→Y (3)
17Y→Y (14)14Y→Y (13);
N→Y (2)
15Y→Y (13);
Y→N (2)
15Yes
0N→Y (3)3Y→N (2)2N→Y (2)2No
University staff doing approved research into whether doctors are prescribing medicines appropriately
Y→Y (11);
N→Y (3)
14Y→Y (11);
Y→N (3)
14Y→Y (8);
N→Y (7)
15Y→Y (8);
Y→N (1)
9Yes
Y→N (3)3N→Y (3)3Y→N (1);
N→N (1)
2N→Y (7);
N→N (1)
8No
Staff employed by local authorities planning the future need for residential care homes
Y→Y (3);
N→Y (3)
6Y→Y (3);
Y→N (3)
6Y→Y (3);
N→Y (7)
10Y→Y (3);
Y→N (1)
4Yes
N→N (8);
Y→N (3)
11N→Y (3);
N→N (8)
11N→N (6);
Y→N (1)
7N→Y (7);
N→N (6)
13No
Staff employed by a private company being paid by a hospital NHS trust to compare the number of people dying after surgery with
other hospitals
Y→Y (1);
N→Y (5)
6Y→Y (1)1Y→Y (5);
N→Y (5)
10Y→Y (5)5Yes
N→N (11)11N→Y (5);
N→N (11)
16N→N (7)7N→Y (5);
N→N (7)
12No
Staff employed by an insurance company aiming to set health insurance premiums accurately
N→Y (1)10Y→Y (1);
N→Y (2)
3Y→Y (1);
Y→N (1)
2Yes
N→N (16)16N→Y (1);
N→N (16)
17N→N (13);
Y→N (1)
14N→Y (2);
N→N (13)
15No
Staff employed by a pharmaceutical company investigating whether they should begin research into a new drug for a genetic disease for
which there is currently no treatment
Y→Y (4);
N→Y (6)
10Y→Y (4);
Y→N (1)
5Y→Y (7);
N→Y (5)
12Y→Y (7)7Yes
N→N (6);
Y→N (1)
7N→Y (6);
N→N (6)
12N→N (5)5N→Y (5);
N→N (5)
10No
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Figure 1. Numbers of jurors who changed their answers to question 1 of the jury mission.
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Table 5. Votes on subquestions of the jury mission completed during the writing of the jury report. NHS: National Health Service.
Jury 2Jury 1Questions and answer options
Vote 1A. Should the NHS body be allowed to create these records about you and other patients?
1317Yes
40No
Vote 1B. If such records were created, should they only publish information about what they plan to do or allow a patient option (type un-
specified)
58Publish only
129Patient option
Vote 1C. Should individuals have the option to opt in or opt out?
51Opt in
1216Opt out
Jury Reports
In addition to the questionnaires above, jurors voted separately
on three individual aspects of question 1, by private poll, during
the writing of the report with the facilitator (Table 5). Voting
on each subquestion was undertaken over the afternoon of day
2 (vote 1A) and throughout day 3 (votes 1B and 1C). As a
consequence, jurors could and did change their opinions during
later votes without being able to change the vote they had given
for earlier questions. Thus, in jury 1, for example, only 9 jurors
voted for patient input in vote 1B, but all were required to
choose between two different types of patient input in vote 1C.
The reasons for changing their minds could be either based on
individual rights or pragmatism. Two jury members from jury
1 stated:
I changed my mind following this discussion, yeah,
well I would have said that they should just announce
it [publish] because I thought if they are going to do
it [use data], do it so it is accurate and everybody is
included in it. But now I am thinking, well human
rights, should people have a decision, you know,
whether to be included or not, yeah.
I was thinking publish but, in reality, if we give people
an option, I don’t think they will opt out as much, but
if you don’t give them an option most people will go
off [get angry].
Use of Data
In vote 1A, all jurors in jury 1, and all but 4 jurors in jury 2,
voted that the NHS should be allowed to create linked records
(Table 5). The reason most commonly voted for by both juries
was that more detailed and complete data would produce more
accurate evidence, which can lead to more effective, more
cost-effective health care through the NHS (see Multimedia
Appendix 2). Other reasons included that personalized medicine
and treatments could only be discovered and used effectively
through use of more complete data and records and that data
use would help identify ineffective drugs and treatments sooner
so that they can be removed from use and increase patient safety.
The main argument mentioned by most jury members against
creating and sharing linked patient records (regardless of
whether they voted in favor of still doing it) concerned
transparency of use. They felt that, without a clear understanding
of who would be regulating the data and making decisions about
access, it was difficult to support the creation of new records.
In addition, there were concerns that this would benefit
researchers or companies rather than individual patients, as
explained by this juror from jury 2:
What proof is there that the general public would be
any better off in terms of that research with all the
data being in one place, then? Whereas at the moment
there is all this research going on anyway, but it is
more difficult for the researchers and the private
companies to get the information, because they have
to go all over for it. So is there any evidence to prove
that it would be better than what it is at the moment?
There were concerns that despite safeguards, data and records
may not be secure and may be accessed by individuals or
organizations without proper permission or legal authority, or
for reasons other than where originally authorized. In addition,
there were concerns that data may be used by private companies
for commercial gain rather than for the benefit of patients and
the public, or sold on to other companies.
Patient Choice
The issue of whether there should be patient choice (either opt
out or opt in), or whether the NHS body should merely follow
the minimum legal requirements of publishing that data use had
taken place, divided both juries. In jury 1, 8 people voted to
publish only, whereas in jury 2, only 5 people voted for this.
The reasons given were that this would ensure more accurate,
complete data when all records are included, which would be
of greater benefit to the population and that it would save time
and money through a much more streamlined, efficient process.
Reasons given why patients should have input included that
there was an expectation that people should be able to have
autonomy and freedom of choice by having control over their
own data and records and choosing whether or not their record
is included and that it would allow individuals to maintain their
confidence in doctors and other health care settings where trust
is critical. In addition, it was suggested that the process of
obtaining patient input would allow greater transparency in how
records are used and shared.
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Jury 1 had more members suggesting an opt-out model in
comparison with jury 2. The most frequently selected reason
they gave for suggesting this model was that more people would
be included in the data, and this would lead to more accurate
results and more representative samples of the population, and
this in the end would lead to more rigorous research and better
treatments. Other reasons included that this would be more
effective in terms of time and money, as it was an easier and
more convenient option for individuals. The alternative would
take an enormous effort and may still not properly provide the
opportunity to every individual to make an informed decision.
This option would allow those who may simply be undecided
(but not opposed) to still contribute to research and
improvements in health care. The reasons that jurors suggested
for an opt-in option included that this option would require the
organization to conduct an information campaign to educate
the public and would mean that individuals whose data were
used in analysis could make an informed decision to be included.
Data Access
When considering who should get access to data, the two juries
had very similar rationales, which were written in the report
that they produced at the end of the third day. Both thought that
public benefit was a key justification for access. Jury 1 was
more strongly supportive of sharing patient records for public
benefit, whereas jury 2 was more cautious and sought to give
patients more control. In particular, they concluded that
organizations and individuals who should be granted access to
these records tend to demonstrate similar characteristics.
Typically, these organizations clearly demonstrated that the
primary goal for using the data was for public benefit (such as
improved medical care and treatments, improved public health,
or management of public funds) and made a clear and
compelling case for why they need these patient records. They
provided clear justification for how and why the data would be
used, why it was relevant to their efforts, with whom it will be
shared, and only access records they needed to perform their
data analysis and could not get adequate data from other sources.
The organizations showed a clear, relevant connection between
the issues they are addressing and the information contained in
these records, had a track record of protecting data and records,
and could be trusted to maintain control of data without sharing
and have controls in place to properly secure the data and
safeguard against internal misuse. Finally, these organizations
needed access to the data to conduct urgent and/or timely
analysis.
The reasons the juries gave for why organizations should not
have access to the data included several that were the opposite
of the reasons for access, such as organizations that did not
clearly indicate that the primary use of the data is for public
benefit, who may use the data solely for private gain or
commercial profit, or who did not have a trusted track record
for protecting data. In addition, they might use the data to exploit
or manipulate individuals or populations or might manipulate
the data to support their own agenda.
Discussion
Principal Findings
The findings of the citizens’ jury work highlight that, when
informed of both the risks and opportunities associated with
health data sharing, members of the public believe an
individual’s right to privacy should not prevent research that
can benefit patients overall. The juries also concluded that
patients should be notified of any such scheme and have the
right to opt out if they so choose. Many, but not all, jurors
became less skeptical about health data sharing, as they became
better informed of its benefits and risks.
Attitudes to Data Use
The findings from this study support the contention that some
members of the public believe that NHS records are a public
resource, paid for by public money, and therefore, should be
used for research for the public benefit [27,28]. Few jurors
objected to the use of health data per se, but many wanted, as
a minimum, to be told that such uses were happening and to be
given an option to opt out. It reinforces the fact that the social
license, or the societal expectations as to how deidentified data
should be used, is not necessarily the same as what is
permissible by law [4].
There were both individual and aggregate changes in attitude,
which has been found in some [8] but not all [29,30] previous
studies in this area. The jury members had the opportunity to
learn about and deliberate on the general use of linked health
data over the course of 3 days, which may well have contributed
to how they changed their opinions. For most of the jury
members, this change related to becoming more accepting of
less patient control over the use of data or more pragmatic about
the need for slightly more patient control, depending on their
initial views. However, two jury members changed their mind
quite strikingly and became much more insistent upon greater
patient control.
The reasons for opinion changes were not explicitly ascertained
in this study. Other studies have found that the provision of
general information [31] or information about the impact of
selection bias [8] may be important in changing opinions toward
greater acceptance of use of deidentified data without explicit
consent. Other studies have shown that, during focus groups,
people change their mind to become more accepting about such
data use, rather than the reverse [11,32]. However, this study
also found that, for a minority of people, their opinion changed
toward being more skeptical about data use. From the
perspective of public engagement about data use and linkage,
this suggests that some individuals may well receive the same
information but reach different conclusions to their peers,
perhaps by applying different values. It also calls into question
the assumption that public distrust will necessarily be addressed,
such as the deficit model of public understanding of science,
by simply providing greater dissemination of information
[33,34].
Many of the jurors changed their minds from preferring either
no public input or an opt-in model to preferring an opt-out
model. Hill and colleagues found a lack of consensus in the
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international literature on a model of consent that was preferred
by the public [8]. Taylor and Taylor found, in their small-scale
study, that although some people may well prefer opt-in models,
pragmatically, they would be willing to accept opt-out models
[29]. Our study did not test other, more nuanced, models of
consent, such as dynamic consent [35], which enable people to
amend their choices as often as they wish, when they change
their minds as to what they are willing to permit to happen with
data about them.
The jurors wanted data to only be provided to organizations
that could demonstrate that the primary goal for using the data
was for public benefit (either for new treatments or to improve
existing services). In addition, such organizations would have
to be trustworthy because of their previous track record and
existing controls and safeguards against misuse. This is similar
to what has been found elsewhere, both nationally [11,36] and
internationally [9,37]. Although commercially funded research
has been considered unacceptable in some studies [8], some
jurors became more willing to accept such uses by the end of
the jury proceedings. This may reflect that why commercial
research was being conducted (eg, for public benefit) mattered
more than who was conducting it [11].
Use of Citizens’ Juries
As has been found in other studies [38], this work shows that
citizens are capable of critically evaluating expert opinion
presented to them, identifying and seeking out any additional
knowledge they need by asking questions from the witnesses,
and then using deliberation to reach an agreed opinion. Such
deliberation went on throughout the jury process, as was seen
when jury members described changing opinions following
discussions with their peers and the differences seen in the
prejury and postjury questionnaires.
These citizens’ juries were conducted as close as possible to
the ideal suggested in a recent systematic review [18]. Our links
with the Jefferson Center and having a member of their staff
act as lead jury facilitator (KB) ensured that the citizens’ juries
demonstrated the three important characteristics of deliberative
democracy: inclusivity, deliberation, and active citizenship [18].
The selection criteria ensured that people from a broad range
of backgrounds were recruited, including those with opposing
opinions on privacy and whose voices might not otherwise be
heard [39]. The recruitment method was different from that
found in the Jefferson Center manual, which advocated cold
calling random telephone numbers [13]. Even in 2004, the
authors cautioned that 180 calls would be needed to recruit each
juror. Online recruitment and completion of a screening
questionnaire was a 21st century update (approved by the
Jefferson Center) that proved much more efficient, as it required
little staff time to identify potential jurors.
By paying jurors appropriately for their time, it was possible to
ensure that participants were representative of the population
and not limited to the subgroup of people with sufficient
resources to enable them to engage in a lengthy volunteer
activity. Citizens’ juries use panels that are selected to be
representative of the population [13]. The Jefferson Center
manual highlights that criteria should be both demographic and
attitudinal, with targets based on existing data. Hence, we used
a national census for criteria based on demographic data [19]
and a recent survey of public opinion on balancing privacy
against information sharing for privacy base criteria [20]. We
acknowledge that this produced a jury with more people in favor
of data sharing, but this reflects the views of the overall British
population. In a small sample of 18 people for each jury, it was
important that we did not by chance recruit a disproportionate
number of people who were very supportive of information
sharing, or a disproportionate number of people who were very
privacy conscious and cautious about information sharing.
The witnesses presented diverse viewpoints, and adequate time
was allowed for jurors to question and challenge the witnesses.
More than half the available time was given to jury deliberation,
which was conducted in small groups with varying participants,
to ensure that jurors interacted with all others. The evidence
from the videos shows the care with which the jurors approached
their role. The jurors were told from the beginning that the
findings from the juries would be fed back to policy makers to
ensure active citizenship. Twelve jurors (6 jurors from each
jury) were invited to the postjury workshop where they
successfully engaged with the invited stakeholders, including
national policy makers.
The findings from citizens’ juries are qualitative in nature, and
therefore, the findings are not intended to be generalizable in a
statistical sense. As described by Lincoln and Guba [40],
qualitative research aims for transferability by showing how
the findings may be applicable to other contexts. To achieve
this, the jury process and materials have been published on the
Web [26], alongside this paper, to increase transparency and
allow other readers to consider whether the findings are
applicable in broader contexts.
Bias, both conscious and unconscious, is an important criticism
of citizens’ juries [41]. Despite the efforts of the researchers
and the independent oversight panel, to ensure that jurors were
presented with balanced information to ensure overall fairness,
some jurors reported a perception of bias. The witnesses had
been chosen so that one set were intentionally impartial and one
set were intentionally partial and aiming to present a particular
side of the arguments to the jurors relative to the mission. There
may have been a lack of clarity about this for several jurors,
which could have led to these impressions. This suggests that
bias in citizens’ juries can be monitored and minimized, but not
totally eliminated.
It could be argued that deliberative methods should be used for
making complex policy decisions. There is some evidence from
the literature that people are happy to have an ethics committee
make decisions about whether to approve the use of data for
individual research studies [42]. In addition, there have been
centuries of experience of using a 12-person jury in criminal
trials. It has been suggested that citizens’ juries symbolically
represent the community [41,43]. Nonetheless, citizens’ juries
such as the ones conducted here are not usually given public
accountability for their decisions and therefore, may be less
acceptable to members of the general public.
From a practical perspective, however, deliberative methods
such as citizens’ juries are not a reasonable choice for all policy
decisions because they are so resource-intensive. They could
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be a good choice for situations where the topics are both
important and potentially intractable or where democratic
legitimacy is needed for decisions [44]. In addition, there is no
expectation that the methodology should (or indeed could) be
scaled up to provide a large-scale public engagement activity
itself. Alternative activities that are designed to reach large
numbers of citizens, however, can be informed by the knowledge
gained from having previously conducted citizens’ juries.
Conclusions
Our citizens’ jury method was successful in enabling members
of the public to deliberate and make decisions about a complex
policy problem. Many jurors became less skeptical about health
data sharing, as they became better informed of its benefits and
risks. Most jurors wanted public input in the form of information
provision and the right to opt out. This was one of only a few
studies to show that during a deliberative process, a small
minority of people become more skeptical about data use, rather
than less. This suggests that public engagement about the data
use cannot assume that merely providing more public
information will equal more public trust.
The deliberative method used in this study may help uncover
often-overlooked opportunities for policy makers to engage
meaningfully and substantively with the public about technical,
and potentially divisive, public policy issues—especially those
that have been recently controversial. This research demonstrates
that citizens’ juries can be an effective model for engaging the
public on policy issues that balance competing issues such as
potential risks to individuals, the pursuit of commercial profit,
the search for answers to research questions by academic
institutions, and the possibility of direct public benefit for
society as a whole. Further research is needed as to whether
citizens’ juries would be acceptable to the public as a way to
have an informed set of peers make decisions on their behalf.
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